{"id":38269,"date":"2026-08-26T12:17:14","date_gmt":"2026-08-26T12:17:14","guid":{"rendered":"https:\/\/itbusinesstoday.com\/?p=38269"},"modified":"2026-08-26T12:17:14","modified_gmt":"2026-08-26T12:17:14","slug":"takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry","status":"publish","type":"post","link":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","title":{"rendered":"\u6b66\u7530\u85ac\u54c1\u306e\u300cORZEYFUL\u300d\u306e\u627f\u8a8d\u306f\u3001\u65e5\u672c\u306e\u30cb\u30e5\u30fc\u30ed\u30c6\u30c3\u30af\u7523\u696d\u306b\u3068\u3063\u3066\u65b0\u305f\u306a\u7bc0\u76ee\u3068\u306a\u308a\u307e\u3059"},"content":{"rendered":"

\u539a\u751f\u52b4\u50cd\u7701\u304c\u6b66\u7530\u85ac\u54c1\u5de5\u696d\u304c\u88fd\u9020\u3059\u308b\u300c\u30aa\u30eb\u30bc\u30a4\u30d5\u30eb\u300d\u3068\u3044\u3046\u533b\u85ac\u54c1\u3092\u627f\u8a8d\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u65e5\u672c\u306e\u533b\u85ac\u54c1\u30fb\u30d8\u30eb\u30b9\u30b1\u30a2\u6280\u8853\u7523\u696d\u306f\u65b0\u305f\u306a\u5c55\u958b\u306e\u6642\u4ee3\u3092\u8fce\u3048\u3088\u3046\u3068\u3057\u3066\u3044\u307e\u3059\u3002\u3053\u306e\u533b\u85ac\u54c1\u306f\u3001\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u3068\u3044\u3046\u75be\u60a3\u3092\u6301\u3064\u6210\u4eba\u3092\u5bfe\u8c61\u3068\u3057\u305f\u3082\u306e\u3067\u3059\u3002.<\/p>\n

The approval came out on August 24 2026. It is very important because ORZEYFUL is the medicine of its kind that is taken by mouth. It works on a part of the brain called the orexin receptor 2. This medicine helps with the root cause of the condition, which’s a lack of orexin. It does not just treat the symptoms. The medicine was created by scientists at Takeda in Japan. This approval shows that research, from Japan can lead to a medicine that is used by patients.
\n\u3053\u306e\u9032\u5c55\u306f\u3001\u6b66\u7530\u85ac\u54c1\u4ee5\u5916\u306b\u3082\u6ce2\u53ca\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u308c\u306f\u3001\u5275\u85ac\u3001\u795e\u7d4c\u79d1\u5b66\u7814\u7a76\u3001\u304a\u3088\u3073\u5148\u7aef\u533b\u85ac\u54c1\u958b\u767a\u306b\u304a\u3051\u308b\u65e5\u672c\u306e\u7d99\u7d9a\u7684\u306a\u5f37\u307f\u3092\u6d6e\u304d\u5f6b\u308a\u306b\u3059\u308b\u4e00\u65b9\u3067\u3001\u81e8\u5e8a\u7814\u7a76\u3001\u30c7\u30b8\u30bf\u30eb\u30d8\u30eb\u30b9\u3001\u8a3a\u65ad\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u6280\u8853\u306b\u643a\u308f\u308b\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u65b0\u305f\u306a\u30d3\u30b8\u30cd\u30b9\u30c1\u30e3\u30f3\u30b9\u3092\u751f\u307f\u51fa\u3059\u53ef\u80fd\u6027\u3082\u3042\u308a\u307e\u3059\u3002.<\/p>\n

ORZEYFUL\u3001\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u6cbb\u7642\u3078\u306e\u65b0\u305f\u306a\u30a2\u30d7\u30ed\u30fc\u30c1\u3092\u767a\u8868<\/h3>\n

\u539a\u751f\u52b4\u50cd\u7701\u304c\u6b66\u7530\u85ac\u54c1\u306e\u300c\u30aa\u30eb\u30bc\u30a4\u30d5\u30eb\u300d\u3092\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306e\u6210\u4eba\u60a3\u8005\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u85ac\u3068\u3057\u3066\u627f\u8a8d\u3057\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u65e5\u672c\u306e\u88fd\u85ac\u304a\u3088\u3073\u30d8\u30eb\u30b9\u30b1\u30a2\u6280\u8853\u5206\u91ce\u306f\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u306e\u6bb5\u968e\u306b\u5165\u3063\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306f\u3001\u899a\u9192\u3068\u7761\u7720\u306e\u8abf\u7bc0\u306b\u95a2\u4e0e\u3059\u308b\u795e\u7d4c\u30da\u30d7\u30c1\u30c9\u3067\u3042\u308b\u30aa\u30ec\u30ad\u30b7\u30f3\u306e\u6b20\u4e4f\u3092\u7279\u5fb4\u3068\u3059\u308b\u3001\u307e\u308c\u306a\u795e\u7d4c\u75be\u60a3\u3067\u3059\u3002\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306e\u60a3\u8005\u3055\u3093\u306f\u3001\u65e5\u4e2d\u306e\u7720\u6c17\u3001\u30ab\u30bf\u30d7\u30ec\u30af\u30b7\u30fc\u3001\u591c\u9593\u306e\u7761\u7720\u969c\u5bb3\u306a\u3069\u306e\u75c7\u72b6\u306b\u60a9\u307e\u3055\u308c\u3001\u5b66\u6821\u3084\u4ed5\u4e8b\u3001\u65e5\u5e38\u751f\u6d3b\u306b\u652f\u969c\u3092\u304d\u305f\u3059\u3053\u3068\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u6b66\u7530\u85ac\u54c1\u306b\u3088\u308b\u3068\u3001\u300cORZEYFUL\u300d\u306fOX2R\u53d7\u5bb9\u4f53\u3092\u7279\u7570\u7684\u306b\u6d3b\u6027\u5316\u3057\u3001\u30aa\u30ec\u30ad\u30b7\u30f3\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u306e\u56de\u5fa9\u3092\u52a9\u3051\u308b\u3068\u306e\u3053\u3068\u3067\u3059\u3002\u300cORZEYFUL\u300d\u306f\u3001\u4e16\u754c\u898f\u6a21\u3067\u5b9f\u65bd\u3055\u308c\u305f\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u300cFirstLight\u300d\u304a\u3088\u3073\u300cRadiantLight\u300d\u306b\u304a\u3044\u3066\u3001\u65e5\u4e2d\u306e\u7720\u6c17\u3084\u30ab\u30bf\u30d7\u30ec\u30af\u30b7\u30fc\u306a\u3069\u3001\u7b2c1\u578b\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc\u306e\u3044\u304f\u3064\u304b\u306e\u75c7\u72b6\u306b\u304a\u3044\u3066\u7d71\u8a08\u7684\u306b\u6709\u610f\u306a\u6539\u5584\u304c\u8a8d\u3081\u3089\u308c\u305f\u3053\u3068\u3092\u53d7\u3051\u3001\u627f\u8a8d\u3055\u308c\u307e\u3057\u305f\u3002.<\/p>\n

\u4eca\u56de\u306e\u627f\u8a8d\u306f\u3001\u4e2d\u56fd\u304a\u3088\u3073\u7c73\u56fd\u3067\u306e\u627f\u8a8d\u306b\u7d9a\u304d\u3001\u300cORZEYFUL\u300d\u306b\u3068\u3063\u3066\u91cd\u8981\u306a\u898f\u5236\u5f53\u5c40\u306e\u627f\u8a8d\u3068\u306a\u308a\u307e\u3059\u3002.<\/p>\n

\u65e5\u672c\u306e\u88fd\u85ac\u696d\u754c\u306b\u3068\u3063\u3066\u3001\u3053\u306e\u51fa\u6765\u4e8b\u306f\u5358\u306a\u308b\u65b0\u88fd\u54c1\u306e\u767a\u58f2\u306b\u3068\u3069\u307e\u308a\u307e\u305b\u3093\u3002\u3053\u308c\u306f\u3001\u795e\u7d4c\u79d1\u5b66\u3078\u306e\u9577\u671f\u7684\u306a\u6295\u8cc7\u304c\u3001\u6700\u7d42\u7684\u306b\u306f\u307e\u3063\u305f\u304f\u65b0\u3057\u3044\u7a2e\u985e\u306e\u6cbb\u7642\u6cd5\u3092\u751f\u307f\u51fa\u3059\u3053\u3068\u304c\u3067\u304d\u308b\u3053\u3068\u3092\u793a\u3057\u3066\u3044\u308b\u306e\u3067\u3059\u3002.
\n\u65e5\u672c\u306e\u7814\u7a76\u958b\u767a\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306f\u3001ORZEYFUL\u306e\u6210\u529f\u304b\u3089\u6069\u6075\u3092\u53d7\u3051\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002ORZEYFUL\u306e\u6210\u529f\u306f\u3001\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304a\u3088\u3073\u88fd\u85ac\u7814\u7a76\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3078\u306e\u95a2\u5fc3\u3092\u9ad8\u3081\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>\n

\u5275\u85ac\u306f\u3001\u9ad8\u5ea6\u306a\u5b9f\u9a13\u5ba4\u6280\u8853\u3001\u8a08\u7b97\u751f\u7269\u5b66\u3001\u81e8\u5e8a\u8a66\u9a13\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u304a\u3088\u3073\u30c7\u30fc\u30bf\u5206\u6790\u306b\u307e\u3059\u307e\u3059\u4f9d\u5b58\u3059\u308b\u3088\u3046\u306b\u306a\u3063\u3066\u3044\u307e\u3059\u3002\u65e5\u672c\u306e\u88fd\u85ac\u4f1a\u793e\u306f\u3001\u795e\u7d4c\u75be\u60a3\u3084\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u6cd5\u3092\u63a2\u6c42\u3057\u3066\u3044\u307e\u3059\u3002\u7814\u7a76\u958b\u767a\u3092\u652f\u3048\u308b\u6280\u8853\u306b\u5bfe\u3059\u308b\u9700\u8981\u306f\u3001\u4eca\u5f8c\u9ad8\u307e\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u4eba\u5de5\u77e5\u80fd\u3082\u307e\u305f\u3001\u5927\u304d\u306a\u5f71\u97ff\u3092\u4e0e\u3048\u3046\u308b\u5206\u91ce\u306e\u4e00\u3064\u3067\u3059\u3002AI\u3084\u6a5f\u68b0\u5b66\u7fd2\u306f\u3001\u7814\u7a76\u8005\u304c\u30c7\u30fc\u30bf\u30bb\u30c3\u30c8\u3092\u5206\u6790\u3057\u3001\u751f\u7269\u5b66\u7684\u30d1\u30bf\u30fc\u30f3\u3092\u7279\u5b9a\u3057\u3001\u6709\u671b\u306a\u5275\u85ac\u5019\u88dc\u3092\u898b\u3064\u3051\u308b\u30d7\u30ed\u30bb\u30b9\u3092\u6539\u5584\u3059\u308b\u306e\u306b\u5f79\u7acb\u3061\u307e\u3059\u3002ORZEYFUL\u306e\u79d1\u5b66\u7684\u767a\u898b\u305d\u306e\u3082\u306e\u306fAI\u306b\u3088\u3063\u3066\u3082\u305f\u3089\u3055\u308c\u305f\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3057\u304b\u3057\u3001\u5927\u624b\u88fd\u85ac\u696d\u754c\u3067\u306f\u3001\u958b\u767a\u30d7\u30ed\u30bb\u30b9\u5168\u4f53\u3092\u901a\u3058\u3066\u3053\u3046\u3057\u305f\u6280\u8853\u306e\u5229\u7528\u304c\u307e\u3059\u307e\u3059\u5e83\u304c\u3063\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u3053\u308c\u306b\u3088\u308a\u3001\u65e5\u672c\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306f\u3001\u533b\u7642\u5206\u91ce\u3068\u5207\u308a\u96e2\u3057\u3066\u6d3b\u52d5\u3059\u308b\u306e\u3067\u306f\u306a\u304f\u3001\u4f01\u696d\u3068\u9023\u643a\u3059\u308b\u6a5f\u4f1a\u3092\u5f97\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>\n

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u3088\u308a\u5927\u304d\u306a\u6280\u8853\u5e02\u5834\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059<\/h3>\n

ORZEYFUL\u306f\u307e\u305f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u7814\u7a76\u304c\u65e5\u672c\u306e\u30d3\u30b8\u30cd\u30b9\u306b\u3068\u3063\u3066\u3044\u304b\u306b\u91cd\u8981\u3067\u3042\u308b\u304b\u306b\u3064\u3044\u3066\u3082\u6307\u6458\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u85ac\u3092\u958b\u767a\u3059\u308b\u306e\u306f\u96e3\u3057\u3044\u3088\u3046\u3067\u3059\u3002\u81e8\u5e8a\u8a66\u9a13\u306b\u306f\u88ab\u9a13\u8005\u304c\u5fc5\u8981\u3067\u3042\u308a\u3001\u9577\u671f\u306b\u308f\u305f\u308b\u30c7\u30fc\u30bf\u3082\u6c42\u3081\u3089\u308c\u307e\u3059\u3002\u30c7\u30b8\u30bf\u30eb\u30c4\u30fc\u30eb\u3092\u6d3b\u7528\u3059\u308c\u3070\u3001\u88fd\u85ac\u4f1a\u793e\u306f\u60a3\u8005\u3092\u63a2\u3057\u51fa\u3057\u3001\u9060\u9694\u304b\u3089\u7d4c\u904e\u3092\u628a\u63e1\u3057\u3001\u85ac\u304c\u8ca9\u58f2\u3055\u308c\u305f\u5f8c\u3082\u5b9f\u4e16\u754c\u30c7\u30fc\u30bf\uff08RE\uff09\u3092\u53ce\u96c6\u3059\u308b\u3053\u3068\u304c\u53ef\u80fd\u306b\u306a\u308a\u307e\u3059\u3002.<\/p>\n

\u533b\u7642\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u30ec\u30b8\u30b9\u30c8\u30ea\u3001\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3001\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u30c7\u30fc\u30bf\u5171\u6709\u3068\u3044\u3063\u305f\u5206\u91ce\u306b\u30d3\u30b8\u30cd\u30b9\u30c1\u30e3\u30f3\u30b9\u3092\u898b\u51fa\u3059\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>\n

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u88fd\u85ac\u4f1a\u793e\u3001\u75c5\u9662\u3001\u5927\u5b66\u3001\u305d\u3057\u3066\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306e\u9593\u3067\u3001\u3088\u308a\u7dca\u5bc6\u306a\u9023\u643a\u3092\u3082\u305f\u3089\u3059\u53ef\u80fd\u6027\u304c\u3042\u308b\u3068\u601d\u3044\u307e\u3059\u3002.
\n\u65e5\u672c\u306e\u7814\u7a76\u958b\u767a\u74b0\u5883\u306f\u3001\u3053\u306e\u3053\u3068\u304b\u3089\u591a\u304f\u306e\u6069\u6075\u3092\u53d7\u3051\u308b\u3053\u3068\u304c\u3067\u304d\u308b\u3067\u3057\u3087\u3046\u3002.<\/p>\n

ORZEYFUL\u306e\u6210\u529f\u306f\u3001\u65e5\u672c\u306e\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u304a\u3088\u3073\u88fd\u85ac\u7814\u7a76\u74b0\u5883\u3078\u306e\u95a2\u5fc3\u3092\u9ad8\u3081\u308b\u304d\u3063\u304b\u3051\u3068\u306a\u308b\u304b\u3082\u3057\u308c\u307e\u305b\u3093\u3002.<\/p>\n

\u533b\u85ac\u54c1\u306e\u958b\u767a\u306f\u3001\u9ad8\u5ea6\u306a\u5b9f\u9a13\u6a5f\u5668\u3001\u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u3092\u6d3b\u7528\u3057\u305f\u751f\u7269\u5b66\u3001\u81e8\u5e8a\u8a66\u9a13\u30b7\u30b9\u30c6\u30e0\u3001\u305d\u3057\u3066\u30c7\u30fc\u30bf\u89e3\u6790\u3078\u306e\u4f9d\u5b58\u5ea6\u304c\u9ad8\u307e\u308a\u3064\u3064\u3042\u308a\u307e\u3059\u3002\u65e5\u672c\u306e\u88fd\u85ac\u4f01\u696d\u304c\u8133\u75be\u60a3\u3084\u5e0c\u5c11\u75be\u60a3\u306e\u6cbb\u7642\u6cd5\u3092\u6a21\u7d22\u3059\u308b\u4e2d\u3001\u7814\u7a76\u958b\u767a\u3092\u652f\u3048\u308b\u5c02\u9580\u7684\u306a\u30c4\u30fc\u30eb\u306e\u9700\u8981\u306f\u3055\u3089\u306b\u9ad8\u307e\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

Artificial intelligence is also an area of influence. AI and learning machines can help scientists look at data find biological signs and make the process of finding new medicine better. Even though AI didn’t lead to the discovery behind ORZEYFUL, the whole drug industry is using computer-based tools more and more during the development steps.<\/p>\n

\u3053\u308c\u306b\u3088\u308a\u3001\u65e5\u672c\u306e\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u3068\u3063\u3066\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u5206\u91ce\u3068\u306f\u4e00\u7dda\u3092\u753b\u3057\u305f\u533b\u85ac\u54c1\u4f01\u696d\u3068\u63d0\u643a\u3059\u308b\u6a5f\u4f1a\u304c\u751f\u307e\u308c\u307e\u3059\u3002.<\/p>\n

\u5e0c\u5c11\u75be\u60a3\u306f\u3001\u3088\u308a\u5927\u304d\u306a\u6280\u8853\u5e02\u5834\u3068\u306a\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059<\/h3>\n

\u307e\u305f\u3001ORZEYFUL\u306f\u3001\u65e5\u672c\u306b\u304a\u3051\u308b\u5e0c\u5c11\u75be\u60a3\u306e\u7814\u7a76\u306e\u91cd\u8981\u6027\u3092\u5f37\u8abf\u3057\u3066\u3044\u307e\u3059\u3002.<\/p>\n

\u7279\u5b9a\u306e\u96c6\u56e3\u3092\u5bfe\u8c61\u3068\u3057\u305f\u533b\u85ac\u54c1\u306e\u958b\u767a\u306f\u56f0\u96e3\u3067\u3059\u3002\u305d\u306e\u7406\u7531\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u60a3\u8005\u3092\u7279\u5b9a\u3059\u308b\u65b9\u6cd5\u3084\u3001\u9577\u671f\u306b\u308f\u305f\u3063\u3066\u30c7\u30fc\u30bf\u3092\u53ce\u96c6\u3059\u308b\u4ed5\u7d44\u307f\u304c\u5fc5\u8981\u3068\u306a\u308b\u305f\u3081\u3067\u3059\u3002\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u306f\u3001\u88fd\u85ac\u4f01\u696d\u304c\u60a3\u8005\u3092\u7279\u5b9a\u3059\u308b\u4e0a\u3067\u5f79\u7acb\u3064\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u307e\u305f\u3001\u533b\u85ac\u54c1\u304c\u5e02\u5834\u306b\u6295\u5165\u3055\u308c\u305f\u5f8c\u306e\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3084\u3001\u5b9f\u4e16\u754c\u30c7\u30fc\u30bf\uff08RE\uff09\u306e\u53ce\u96c6\u306b\u304a\u3044\u3066\u3082\u3001\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u304c\u5f79\u7acb\u3064\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u533b\u7642\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u4f01\u696d\u306b\u306f\u3001\u6210\u9577\u306e\u9053\u304c\u958b\u3051\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u3053\u3046\u3057\u305f\u4f01\u696d\u306f\u3001\u30ec\u30b8\u30b9\u30c8\u30ea\u3001\u81e8\u5e8a\u8a66\u9a13\u7ba1\u7406\u3001\u9060\u9694\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u3001\u30c7\u30fc\u30bf\u306e\u76f8\u4e92\u904b\u7528\u6027\u3068\u3044\u3063\u305f\u5206\u91ce\u306b\u53d6\u308a\u7d44\u3080\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002.<\/p>\n

\u4f01\u696d\u306b\u3068\u3063\u3066\u306f\u3001\u3053\u308c\u304c\u30c1\u30fc\u30e0\u30ef\u30fc\u30af\u306e\u5f37\u5316\u306b\u3064\u306a\u304c\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002\u88fd\u85ac\u4f1a\u793e\u3001\u75c5\u9662\u3001\u5927\u5b66\u3001\u305d\u3057\u3066\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u30d7\u30ed\u30d0\u30a4\u30c0\u30fc\u304c\u3001\u4e92\u3044\u306b\u7dca\u5bc6\u306b\u9023\u643a\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308b\u3067\u3057\u3087\u3046\u3002.<\/p>\n

\u65e5\u672c\u306e\u30d8\u30eb\u30b9\u30c6\u30c3\u30af\u5206\u91ce\u306e\u5c06\u6765\u306b\u5411\u3051\u305f\u5f37\u529b\u306a\u30b7\u30b0\u30ca\u30eb<\/h3>\n

\u6b66\u7530\u85ac\u54c1\u306e\u300cORZEYFUL\u300d\u306e\u627f\u8a8d\u306f\u3001\u65e5\u672c\u306e\u88fd\u85ac\u696d\u754c\u304a\u3088\u3073\u305d\u306e\u5e83\u7bc4\u306a\u6280\u8853\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u306b\u3068\u3063\u3066\u306e\u9032\u5c55\u3068\u306a\u308a\u307e\u3059\u3002.<\/p>\n

\u3053\u3061\u3089\u3082\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a CKD\u6cbb\u7642\u85ac\u5e02\u5834\u306f2035\u5e74\u307e\u3067\u306b$10.9B\u306b\u9054\u3057\u3001\u65e5\u672c\u306e\u30d8\u30eb\u30b9\u30c6\u30c3\u30af\u7523\u696d\u3092\u5f8c\u62bc\u3057\u3059\u308b\u898b\u8fbc\u307f\u3067\u3059<\/a><\/h4>\n

\u3053\u306e\u533b\u85ac\u54c1\u306f\u3001\u30ca\u30eb\u30b3\u30ec\u30d7\u30b7\u30fc1\u578b\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6cd5\u3092\u63d0\u4f9b\u3059\u308b\u3068\u3068\u3082\u306b\u3001\u65e5\u672c\u3092\u62e0\u70b9\u3068\u3059\u308b\u795e\u7d4c\u79d1\u5b66\u7814\u7a76\u304c\u3001\u4e16\u754c\u7684\u306b\u610f\u7fa9\u306e\u3042\u308b\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u751f\u307f\u51fa\u3059\u53ef\u80fd\u6027\u3092\u793a\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u3001\u3053\u306e\u533b\u85ac\u54c1\u306e\u5546\u696d\u5316\u306f\u3001\u7814\u7a76\u6280\u8853\u3001\u533b\u7642\u7528\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3001\u533b\u7642\u30c7\u30fc\u30bf\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3001\u304a\u3088\u3073\u30c7\u30b8\u30bf\u30eb\u60a3\u8005\u652f\u63f4\u30b7\u30b9\u30c6\u30e0\u306b\u5bfe\u3059\u308b\u9700\u8981\u3092\u559a\u8d77\u3059\u308b\u53ef\u80fd\u6027\u304c\u3042\u308a\u307e\u3059\u3002.<\/p>\n

\u65e5\u672c\u304c\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001AI\u3001\u30d8\u30eb\u30b9\u30b1\u30a2\u306e\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3078\u306e\u6295\u8cc7\u3092\u7d9a\u3051\u308b\u306b\u3064\u308c\u3001\u88fd\u85ac\u3068\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u306e\u5883\u754c\u7dda\u306f\u307e\u3059\u307e\u3059\u66d6\u6627\u306b\u306a\u3063\u3066\u3044\u304f\u3082\u306e\u3068\u601d\u308f\u308c\u307e\u3059\u3002.<\/p>\n

\u3057\u305f\u304c\u3063\u3066\u3001ORZEYFUL\u306f\u5358\u306a\u308b\u65e5\u672c\u5e02\u5834\u5411\u3051\u306e\u533b\u85ac\u54c1\u3068\u3044\u3046\u3060\u3051\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002\u3053\u308c\u306f\u3001\u65e5\u672c\u767a\u306e\u79d1\u5b66\u7684\u7814\u7a76\u304c\u3001\u3044\u304b\u306b\u6cbb\u7642\u6280\u8853\u3092\u5275\u51fa\u3057\u3001\u56fd\u5185\u306e\u30d8\u30eb\u30b9\u30b1\u30a2\u30fb\u30a8\u30b3\u30b7\u30b9\u30c6\u30e0\u3092\u5f37\u5316\u3057\u3001\u533b\u85ac\u54c1\u3001\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3001\u30c7\u30b8\u30bf\u30eb\u6280\u8853\u306e\u4ea4\u5dee\u70b9\u3067\u4e8b\u696d\u3092\u5c55\u958b\u3059\u308b\u4f01\u696d\u306b\u3068\u3063\u3066\u306e\u6a5f\u4f1a\u3092\u5275\u51fa\u3067\u304d\u308b\u304b\u3092\u793a\u3059\u597d\u4f8b\u3067\u3059\u3002.<\/p>","protected":false},"excerpt":{"rendered":"

Japans medicine and health technology industries are moving into a time of new ideas after the Japanese Ministry of Health Labour and Welfare approved a medicine called ORZEYFUL made by Takeda Pharmaceutical. This medicine is for adults who have a condition called narcolepsy type 1. The approval came out on August 24 2026. It is very important because ORZEYFUL is the medicine of its kind that is taken by mouth. It works on a part of the brain called the orexin receptor 2. This medicine helps with the root cause of the condition, which’s a lack of orexin. It does not just treat the symptoms. The medicine was created by […]<\/p>\n","protected":false},"author":7,"featured_media":38293,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"wprm-recipe-roundup-name":"","wprm-recipe-roundup-description":"","postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""},"footnotes":""},"categories":[89,8098],"tags":[314,15018,15019,575,8700],"ppma_author":[572],"class_list":["post-38269","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-tech","category-news-articles","tag-japan","tag-neurotech-industry","tag-orzeyful","tag-pharmaceutical","tag-takeda"],"yoast_head":"\nTakeda\u2019s ORZEYFUL Approval Signals Neurotech Growth<\/title>\n<meta name=\"description\" content=\"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth\" \/>\n<meta property=\"og:description\" content=\"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/\" \/>\n<meta property=\"og:site_name\" content=\"itbusinesstoday\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-26T12:17:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"ITBT StaffWriter\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"ITBT StaffWriter\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"5\u5206\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth","description":"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","og_locale":"ja_JP","og_type":"article","og_title":"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth","og_description":"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.","og_url":"https:\/\/itbusinesstoday.com\/ja\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","og_site_name":"itbusinesstoday","article_published_time":"2026-08-26T12:17:14+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","type":"image\/webp"}],"author":"ITBT StaffWriter","twitter_card":"summary_large_image","twitter_misc":{"\u57f7\u7b46\u8005":"ITBT StaffWriter","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"5\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#article","isPartOf":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"},"author":{"name":"ITBT StaffWriter","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15"},"headline":"Takeda\u2019s ORZEYFUL Approval Marks New Milestone for Japan\u2019s Neurotech Industry","datePublished":"2026-08-26T12:17:14+00:00","mainEntityOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"},"wordCount":980,"publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","keywords":["Japan","Neurotech Industry","ORZEYFUL","pharmaceutical","Takeda"],"articleSection":["Health Tech","News Articles"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","url":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/","name":"Takeda\u2019s ORZEYFUL Approval Signals Neurotech Growth","isPartOf":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website"},"primaryImageOfPage":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"image":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage"},"thumbnailUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","datePublished":"2026-08-26T12:17:14+00:00","description":"ORZEYFUL\u2019s approval by Takeda for Japan\u2019s neurotech sector, potentially encouraging new investment and innovation in neurological healthcare.","breadcrumb":{"@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#primaryimage","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2026\/08\/Takedas-Orzeyful-secured-Japan-MHLW-approval-for-narcolepsy-type-1.webp","width":1200,"height":800,"caption":"Takedas"},{"@type":"BreadcrumbList","@id":"https:\/\/itbusinesstoday.com\/health-tech\/takedas-orzeyful-approval-marks-new-milestone-for-japans-neurotech-industry\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/itbusinesstoday.com\/"},{"@type":"ListItem","position":2,"name":"Takeda\u2019s ORZEYFUL Approval Marks New Milestone for Japan\u2019s Neurotech Industry"}]},{"@type":"WebSite","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#website","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","description":"","publisher":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#organization","name":"\u30a4\u30c3\u30c8\u30d3\u30b8\u30cd\u30b9\u30c8\u30a5\u30c7\u30a4","url":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Asset-1.png","width":663,"height":275,"caption":"itbusinesstoday"},"image":{"@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/itbusinesstoday-68b209.ingress-baronn.ewp.live\/#\/schema\/person\/94fb575e469aff25a4b938814d050f15","name":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc","image":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png90b3cb23d1d9c08733d969d29ea2d30d","url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","contentUrl":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","caption":"ITBT StaffWriter"},"description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002","sameAs":["https:\/\/itbusinesstoday.com\/"],"url":"https:\/\/itbusinesstoday.com\/ja\/author\/itbt-staffwriter\/"}]}},"authors":[{"term_id":572,"user_id":7,"is_guest":0,"slug":"itbt-staffwriter","display_name":"ITBT StaffWriter","avatar_url":{"url":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png","url2x":"https:\/\/itbusinesstoday.com\/wp-content\/uploads\/2025\/01\/Favicon-1.png"},"author_category":"","first_name":"ITBT","last_name":"StaffWriter","user_url":"https:\/\/itbusinesstoday.com\/","job_title":"","description":"ITBT\u30b9\u30bf\u30c3\u30d5\u30e9\u30a4\u30bf\u30fc\u306f\u3001IT Business Today\u306e\u793e\u5185\u5bc4\u7a3f\u8005\u3067\u3001\u30bf\u30a4\u30e0\u30ea\u30fc\u306a\u30cb\u30e5\u30fc\u30b9\u3068QuickBytes\u306e\u914d\u4fe1\u3092\u62c5\u5f53\u3057\u3066\u3044\u307e\u3059\u3002IT\u3001\u30cf\u30a4\u30c6\u30af\u3001\u4f01\u696d\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306e\u6700\u65b0\u52d5\u5411\u3092\u30ab\u30d0\u30fc\u3057\u3001\u7c21\u6f54\u3067\u30a4\u30f3\u30d1\u30af\u30c8\u306e\u3042\u308b\u6700\u65b0\u60c5\u5831\u3092\u8aad\u8005\u306b\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002"}],"_links":{"self":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/comments?post=38269"}],"version-history":[{"count":1,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269\/revisions"}],"predecessor-version":[{"id":38270,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/posts\/38269\/revisions\/38270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media\/38293"}],"wp:attachment":[{"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/media?parent=38269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/categories?post=38269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/tags?post=38269"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/itbusinesstoday.com\/ja\/wp-json\/wp\/v2\/ppma_author?post=38269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}